Nucala 100 mg/mL (Mepolizumab INJECTION, SOLUTION) 100 mg/mL

Nucala 100 mg/mL is a subcutaneous injection solution containing mepolizumab. It is used to manage specific inflammatory conditions. Learn more about its uses and effects.

Strength

100 mg/mL

Pack Size

1 SYRINGE in 1 CARTON (0173-0892-42) / 1 mL in 1 SYRINGE

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nucala 100 mg/mL is primarily used for the treatment of severe eosinophilic asthma, a condition characterized by high levels of eosinophils, a type of white blood cell. It may also be used for other inflammatory conditions as determined by a healthcare provider. The active ingredient, mepolizumab, works by reducing the number of eosinophils in the blood, which can help manage symptoms associated with these conditions.

Side Effects

Common effects of Nucala 100 mg/mL may include reactions at the injection site, such as redness, swelling, or itching. Some individuals might experience headaches or fatigue. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare professional.

Precautions & Warnings

Nucala 100 mg/mL should be stored as directed to maintain its efficacy. It is important to use this medication exactly as prescribed by a healthcare provider. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions. Do not self-administer without proper guidance.

Avoid Interactions

Nucala 100 mg/mL may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider before starting Nucala. Avoid alcohol while using this medication unless advised otherwise by a healthcare professional.

References

Frequently Asked Questions

Nucala 100 mg/mL is used to manage severe eosinophilic asthma and other inflammatory conditions characterized by high eosinophil levels.

Nucala 100 mg/mL is administered as a subcutaneous injection, typically self-administered with proper training.

Common side effects include injection site reactions, headaches, and fatigue. These effects are usually mild and temporary.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safety.

Nucala 100 mg/mL should be stored according to the instructions provided to maintain its effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.